Lupin Limited — Updates, 09-10-2025: Press Release
09-10-2025 | 03:01 pm
09-10-2025 | 03:01 pm
Lupin initiated a strategic partnership program for its FDA-approved PrecisionSphere™ Long-Acting Injectable (LAI) platform. This aims to collaborate with firms, extending product lifecycles & market reach through improved drug delivery and enhanced patient compliance, signaling strong growth potential.
No comments yet. Be the first to comment!
